business
Palantir Stock Falls Below a Key Price Level. How Low It Could Go.
Palantir Stock Falls Below a Key Price Level. How Low It Could Go.
Read full story on Yahoo Finance → More top storiesAlso covered by
Investing.com
Argenx stock falls after myositis drug trial update
Investing.com
Verastem stock price target maintained at $18 by BTIG on trial data
Investing.com
Deutsche Bank cuts EssilorLuxottica stock price target on FX headwinds
Investing.com
BofA reiterates Neutral on Nike stock, keeps $55 price target
Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop